Comparative Pharmacokinetic and Pharmacodynamic Effects of Delta-8 and Delta-9 THC
Status:
Not yet recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
The current study will investigate the subjective, physiological, and cognitive performance
effects of inhaled and orally ingested Delta-8 tetrahydrocannabinol (THC) in comparison to
both placebo and Delta-9 THC. The purpose of this study is to assess the effects of Delta-8
THC as compared to placebo and Delta-9 THC. Oral fluid, urine, blood, and hair specimens will
be collected from participants.
Phase:
Phase 1
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
Substance Abuse and Mental Health Services Administration (SAMHSA)